As of 2025-03-15, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (6.76) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -261.4%.
The range of the Relative Valuation is (6.56) - (18.27) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.0x - 14.8x | 3.7x |
| Forward P/E multiples | 4.6x - 12.7x | 5.7x |
| Fair Price | (6.56) - (18.27) | (6.76) |
| Upside | -256.6% - -536.1% | -261.4% |
| Date | P/E |